Can mindfulness ease cancer stress for latino families?
NCT ID NCT04870788
First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 2 times
Summary
This study is testing a culturally adapted mindfulness program for Latino cancer patients and their family caregivers. The goal is to see if the program is practical and helpful for reducing stress and anxiety. About 68 patient-caregiver pairs will take part, with some starting the program right away and others after a 12-week wait.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mindfulness-based stress reduction program
- What this could lead to
- If it works, this could provide a practical, culturally tailored way to ease anxiety and improve quality of life for Latino cancer patients and their families.
- What could go wrong
- This is a small, early-stage feasibility study (68 participants) focused on whether the program is acceptable and doable, not on proving it works. Results may not apply to all Latino communities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
68 people
The number who actually took part.
- Started
-
Mar 2021
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with a stage III-IV solid tumor * On active treatment * Self-identify as Hispanic/Latino * ECOG (Eastern Cooperative Oncology Group) performance status of =\< 2 * Willing to participate in the study with a family caregiver (e.g., spouse, adult child) with whom they currently reside and who consents to participate Exclusion Criteria: * At least 18 years old * Able to speak English or Spanish * Have access to the internet * Able to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced malignant solid neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Oral drug that targets two cancer drivers tested in first human study
- Mitochondria-Targeting drug gamitrinib tested for first time in humans
- Can a Two-Drug combo outsmart advanced cancer?
- Can an experimental pill boost cancer immunotherapy? early trial puts HG146 to the test
- New injectable drug tested for safety in Hard-to-Treat solid tumors
- New antibody drug conjugate tested against advanced cancers